IDO1 and cancer: In particular, even at the early stage of cancer, IDO activity is enhanced (Lyon et al. 2011) and such activity, in the vast majority of studies, has been associated with a poorer prognosis (Godin-Ethier et al. 2011; Gostner et al. 2015).